BLUE – bluebird bio, Inc.

bluebird bio, Inc.

BLUE

$4.68

Name : bluebird bio, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $45,817,524.00

EPSttm : -24.84

bluebird bio, Inc.

$4.68

3.51%

$0.17

Float Short %

19.12

Margin Of Safety %

Put/Call OI Ratio

0.24

EPS Next Q Diff

EPS Last/This Y

25.14

EPS This/Next Y

-11.8

Price

4.82

Target Price

6.5

Analyst Recom

2.8

Performance Q

-46.23

Relative Volume

0.51

Beta

0.21

Ticker: BLUE

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-03-11	BLUE	3.98	0.16	10.69	87752
2025-03-12	BLUE	3.86	0.18	17.09	89341
2025-03-13	BLUE	3.73	0.20	19.33	90529
2025-03-14	BLUE	3.74	0.20	6.00	90884
2025-03-17	BLUE	3.96	0.20	0.38	90974
2025-03-18	BLUE	3.95	0.21	18.21	91147
2025-03-19	BLUE	3.91	0.21	6.11	91484
2025-03-20	BLUE	3.94	0.21	2.84	91537
2025-03-21	BLUE	3.89	0.21	3.33	92228
2025-03-24	BLUE	3.9	0.21	120.50	91419
2025-03-25	BLUE	3.87	0.22	0.49	91601
2025-03-26	BLUE	3.79	0.22	1.31	91663
2025-03-27	BLUE	3.78	0.22	8.42	92044
2025-03-28	BLUE	4.07	0.23	5.85	92636
2025-03-31	BLUE	4.88	0.23	0.30	93847
2025-04-01	BLUE	5.31	0.23	2.38	94609
2025-04-02	BLUE	5.04	0.23	2.65	94745
2025-04-03	BLUE	4.88	0.23	0.00	94724
2025-04-04	BLUE	4.94	0.23	0.52	94611
2025-04-07	BLUE	4.72	0.23	0.73	94614
2025-04-08	BLUE	4.81	0.24	0.38	95058
2025-04-09	BLUE	4.82	0.24	16.79	95090
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-03-11	BLUE	3.97	59.7	-	-27.19
2025-03-12	BLUE	3.86	59.7	-	-27.19
2025-03-13	BLUE	3.72	59.7	-	-27.19
2025-03-14	BLUE	3.75	59.7	-	-27.19
2025-03-17	BLUE	3.96	59.7	-	-27.19
2025-03-18	BLUE	3.91	59.7	-	-27.19
2025-03-19	BLUE	3.93	59.7	-	-27.19
2025-03-20	BLUE	3.96	59.7	-	-27.19
2025-03-21	BLUE	3.88	59.7	-	-27.19
2025-03-24	BLUE	3.92	59.7	-	-27.19
2025-03-25	BLUE	3.85	59.7	-	-27.19
2025-03-26	BLUE	3.75	59.7	-	-27.19
2025-03-27	BLUE	3.79	59.7	-	-27.19
2025-03-28	BLUE	4.08	59.7	-	-27.19
2025-03-31	BLUE	4.91	45.9	-	-9.70
2025-04-01	BLUE	5.25	45.9	-	-9.70
2025-04-02	BLUE	5.03	45.9	-	-9.70
2025-04-03	BLUE	4.91	45.9	-	-9.70
2025-04-04	BLUE	4.95	66.4	-	0.30
2025-04-07	BLUE	4.72	66.4	-	0.30
2025-04-08	BLUE	4.82	66.4	-	0.30
2025-04-09	BLUE	4.82	66.4	-	0.30
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-03-11	BLUE	-28.66	-6.61	28.27
2025-03-12	BLUE	-28.66	-6.61	20.69
2025-03-13	BLUE	-28.66	-6.61	20.69
2025-03-14	BLUE	-28.66	-6.61	20.69
2025-03-17	BLUE	-28.65	-5.98	20.69
2025-03-18	BLUE	-28.65	-5.98	20.69
2025-03-19	BLUE	-28.66	-5.98	20.69
2025-03-20	BLUE	-28.66	-5.98	20.69
2025-03-21	BLUE	-28.66	-5.98	20.69
2025-03-24	BLUE	-28.66	-0.37	20.69
2025-03-25	BLUE	-28.66	-0.37	20.69
2025-03-26	BLUE	-28.66	-0.37	19.20
2025-03-27	BLUE	-28.66	-0.37	19.20
2025-03-28	BLUE	-28.65	-0.37	19.20
2025-03-31	BLUE	-28.66	-0.27	19.20
2025-04-01	BLUE	-28.66	-0.27	19.20
2025-04-02	BLUE	-28.55	-0.27	19.12
2025-04-03	BLUE	-5.77	-0.27	19.12
2025-04-04	BLUE	-5.77	-0.27	19.12
2025-04-07	BLUE	-5.77	-0.27	19.12
2025-04-08	BLUE	-5.77	-0.27	19.12
2025-04-09	BLUE	-5.77	-0.27	19.12
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-3.9

Avg. EPS Est. Next Quarter

-0.36

Insider Transactions

-5.77

Institutional Transactions

-0.27

Beta

0.21

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

99.5

Max Drawdown 5-Year %

-99.6

Target Price

6.5

P/E

Forward P/E

3.9

PEG

P/S

0.57

P/B

P/Free Cash Flow

EPS

-24.86

Average EPS Est. Cur. Y

0.3

EPS Next Y. (Est.)

-11.5

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-287.23

Relative Volume

0.51

Return on Equity vs Sector %

743.7

Return on Equity vs Industry %

756.6

EPS 1 7Days Diff

EPS 1 30Days Diff

9.99

EBIT Estimation

bluebird bio, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 248

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for curative severe genetic diseases in the United States. The company's product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ß-thalassemia; LYFGENIA (lovotibeglogene autotemcel) for the treatment of sickle cell disease (SCD) and a history of vaso-occlusive events; and SKYSONA (elivaldogene autotemcel) to treat cerebral adrenoleukodystrophy. Its clinical development programs include HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Somerville, Massachusetts.

stock quote shares BLUE – bluebird bio, Inc. Stock Price stock today

news today BLUE – bluebird bio, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch BLUE – bluebird bio, Inc. yahoo finance google finance

stock history BLUE – bluebird bio, Inc. invest stock market

stock prices BLUE premarket after hours

ticker BLUE fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

BLUE – bluebird bio, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: BLUE

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y